U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826755) titled 'Melatonin Effects on Cardiovascular Disease Mechanisms in the Menopause Transition: a Randomized Clinical Trial' on Feb. 10.
Brief Summary: The purpose of this research is to study the effects of 12 weeks of melatonin supplementation compared to placebo in women who are in the menopause transition (perimenopause) and have high blood pressure.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Perimenopause
Hypertension
Intervention:
DIETARY_SUPPLEMENT: Terry Naturally(R) melatonin 5mg SR
Participants will take SR melatonin 5mg (or placebo) orally 1 hour before bed, for approximately 12 weeks. The study is com...